On this episode we talk with experts Dr. Amy Shapiro, Dr. Maria Elisa Mancuso, Dr. Steve Pipe, Dr. Johnny Mahlangu, and Dr. Lynn Malec to delve into the ongoing evolution of hemophilia therapies. The discussion highlights recent advancements in treatments such as emicizumab, extended half-life factor VIII therapies, and investigates medications in clinical trials like Concizumab, Marstacimab, and Fitusiran. The episode also reflects on the role of treatment individualization and the need for more inclusive research data.
Contributors:
Johnny Mahlangu, MBBCh, MMed, FCPath
Lynn Malec, MD, MSc
Elisa Mancuso, MD
Steven Pipe, MD
Amy Shapiro, MD
Senior Advisor: Donna DiMichele, MD
Hosted & Written by: Patrick James Lynch
Featured Advertiser:
Subscribe to the Global Hemophilia Report
Show Notes:
Connect with the Global Hemophilia Report
Global Hemophilia Report on LinkedIn
Global Hemophilia Report on Twitter
Global Hemophilia Report on Facebook
Connect with BloodStream Media:
I Do, Part 2
From Executive Producers Jennie Garth, Jana Kramer, Amy Robach, and T.J. Holmes. Did you think you met the love of your life and marry him, only to realize it was actually “thank you, next?" Did this jerk cheat on you and leave you feeling alone and hopeless? Don’t make the same mistake twice... Get it right THIS time! Is it time to find true love…again?! If you loved the Golden Bachelor, SILVER just might be your color. Older and wiser, 50 and Fabulous, and ready for a little sex in the city. Everyone has baggage, but you’re not bringing it on this trip. Second Times The Charm. I Do, Part Two. An iHeartRadio podcast...where finding love is the main objective.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The Bobby Bones Show
Listen to 'The Bobby Bones Show' by downloading the daily full replay.